• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂肪细胞更新:与人类脂肪组织形态学的相关性。

Adipocyte turnover: relevance to human adipose tissue morphology.

机构信息

Department of Medicine, Karolinska Institutet at Karolinska University Hospital, Stockholm, Sweden.

出版信息

Diabetes. 2010 Jan;59(1):105-9. doi: 10.2337/db09-0942. Epub 2009 Oct 21.

DOI:10.2337/db09-0942
PMID:19846802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2797910/
Abstract

OBJECTIVE

Adipose tissue may contain few large adipocytes (hypertrophy) or many small adipocytes (hyperplasia). We investigated factors of putative importance for adipose tissue morphology.

RESEARCH DESIGN AND METHODS

Subcutaneous adipocyte size and total fat mass were compared in 764 subjects with BMI 18-60 kg/m(2). A morphology value was defined as the difference between the measured adipocyte volume and the expected volume given by a curved-line fit for a given body fat mass and was related to insulin values. In 35 subjects, in vivo adipocyte turnover was measured by exploiting incorporation of atmospheric (14)C into DNA.

RESULTS

Occurrence of hyperplasia (negative morphology value) or hypertrophy (positive morphology value) was independent of sex and body weight but correlated with fasting plasma insulin levels and insulin sensitivity, independent of adipocyte volume (beta-coefficient = 0.3, P < 0.0001). Total adipocyte number and morphology were negatively related (r = -0.66); i.e., the total adipocyte number was greatest in pronounced hyperplasia and smallest in pronounced hypertrophy. The absolute number of new adipocytes generated each year was 70% lower (P < 0.001) in hypertrophy than in hyperplasia, and individual values for adipocyte generation and morphology were strongly related (r = 0.7, P < 0.001). The relative death rate (approximately 10% per year) or mean age of adipocytes (approximately 10 years) was not correlated with morphology.

CONCLUSIONS

Adipose tissue morphology correlates with insulin measures and is linked to the total adipocyte number independently of sex and body fat level. Low generation rates of adipocytes associate with adipose tissue hypertrophy, whereas high generation rates associate with adipose hyperplasia.

摘要

目的

脂肪组织可能含有少数大脂肪细胞(肥大)或许多小脂肪细胞(增生)。我们研究了脂肪组织形态的潜在重要因素。

研究设计和方法

在 BMI 为 18-60 kg/m(2)的 764 名受试者中比较了皮下脂肪细胞大小和总脂肪质量。形态值定义为测量的脂肪细胞体积与给定体脂质量的曲线拟合所预期的体积之间的差异,并与胰岛素值相关。在 35 名受试者中,通过利用大气(14)C 掺入 DNA 来测量体内脂肪细胞的周转率。

结果

增生(负形态值)或肥大(正形态值)的发生与性别和体重无关,但与空腹血浆胰岛素水平和胰岛素敏感性相关,与脂肪细胞体积无关(β系数=0.3,P<0.0001)。总脂肪细胞数量和形态呈负相关(r=-0.66);也就是说,在明显的增生中总脂肪细胞数量最大,在明显的肥大中最小。每年生成的新脂肪细胞数量减少了 70%(P<0.001),肥大比增生少,并且脂肪细胞生成和形态的个体值密切相关(r=0.7,P<0.001)。脂肪细胞的相对死亡率(每年约 10%)或平均年龄(约 10 年)与形态无关。

结论

脂肪组织形态与胰岛素测量值相关,并与性别和体脂水平无关,与总脂肪细胞数量有关。脂肪细胞生成率低与脂肪组织肥大有关,而生成率高与脂肪组织增生有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d249/2797910/c45c4a6f0171/zdb0011059940003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d249/2797910/ecedd1409ceb/zdb0011059940001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d249/2797910/420313e2639d/zdb0011059940002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d249/2797910/c45c4a6f0171/zdb0011059940003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d249/2797910/ecedd1409ceb/zdb0011059940001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d249/2797910/420313e2639d/zdb0011059940002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d249/2797910/c45c4a6f0171/zdb0011059940003.jpg

相似文献

1
Adipocyte turnover: relevance to human adipose tissue morphology.脂肪细胞更新:与人类脂肪组织形态学的相关性。
Diabetes. 2010 Jan;59(1):105-9. doi: 10.2337/db09-0942. Epub 2009 Oct 21.
2
Adipose tissue morphology predicts improved insulin sensitivity following moderate or pronounced weight loss.脂肪组织形态可预测适度或显著体重减轻后胰岛素敏感性的改善。
Int J Obes (Lond). 2015 Jun;39(6):893-8. doi: 10.1038/ijo.2015.18. Epub 2015 Feb 10.
3
Regional impact of adipose tissue morphology on the metabolic profile in morbid obesity.病态肥胖中脂肪组织形态对代谢特征的区域性影响。
Diabetologia. 2010 Dec;53(12):2496-503. doi: 10.1007/s00125-010-1889-3. Epub 2010 Sep 10.
4
Body fat mass and the proportion of very large adipocytes in pregnant women are associated with gestational insulin resistance.孕妇的体脂肪量和超大脂肪细胞的比例与妊娠胰岛素抵抗有关。
Int J Obes (Lond). 2016 Apr;40(4):646-53. doi: 10.1038/ijo.2015.232. Epub 2015 Nov 13.
5
Adipocyte C1QTNF5 expression is BMI-dependently related to early adipose tissue dysfunction and systemic CTRP5 serum levels in obese children.脂肪细胞C1QTNF5的表达与肥胖儿童早期脂肪组织功能障碍及循环CTRP5血清水平呈体重指数依赖性相关。
Int J Obes (Lond). 2017 Jun;41(6):955-963. doi: 10.1038/ijo.2017.54. Epub 2016 Dec 5.
6
Visceral adipocyte hypertrophy is associated with dyslipidemia independent of body composition and fat distribution in women.内脏脂肪细胞肥大与血脂异常有关,与女性的身体成分和脂肪分布无关。
Diabetes. 2011 May;60(5):1504-11. doi: 10.2337/db10-1039. Epub 2011 Mar 18.
7
Hyperleptinemia is more closely associated with adipose cell hypertrophy than with adipose tissue hyperplasia.高瘦素血症与脂肪细胞肥大的关系比与脂肪组织增生的关系更为密切。
Int J Obes Relat Metab Disord. 2000 Jun;24(6):782-8. doi: 10.1038/sj.ijo.0801227.
8
Subcutaneous adipocyte size and body fat distribution.皮下脂肪细胞大小与身体脂肪分布。
Am J Clin Nutr. 2008 Jan;87(1):56-63. doi: 10.1093/ajcn/87.1.56.
9
Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance.吡格列酮对肥胖和胰岛素抵抗状态下脂肪组织重塑的影响。
Diabetes. 2001 Aug;50(8):1863-71. doi: 10.2337/diabetes.50.8.1863.
10
Adipocyte hypertrophy, inflammation and fibrosis characterize subcutaneous adipose tissue of healthy, non-obese subjects predisposed to type 2 diabetes.脂肪细胞肥大、炎症和纤维化是易患2型糖尿病的健康非肥胖受试者皮下脂肪组织的特征。
PLoS One. 2014 Aug 22;9(8):e105262. doi: 10.1371/journal.pone.0105262. eCollection 2014.

引用本文的文献

1
Claudin Proteins: Their Potential Role in Obesity and Adipose Tissue Signaling, Physiology and Disease.紧密连接蛋白:它们在肥胖、脂肪组织信号传导、生理学及疾病中的潜在作用
Nutrients. 2025 Aug 12;17(16):2611. doi: 10.3390/nu17162611.
2
Orbital Fat is an Observation Model to Provide Insights into Adipocyte Hypertrophy and Hyperplasia During White Adipose Tissue Expansion.眼眶脂肪是一种观察模型,用于深入了解白色脂肪组织扩张过程中的脂肪细胞肥大和增生。
Diabetes Metab Syndr Obes. 2025 Aug 20;18:2977-2984. doi: 10.2147/DMSO.S521845. eCollection 2025.
3
Novel Hyperplastic Expansion of White Adipose Tissue Underlies the Metabolically Healthy Obese Phenotype of Male LFABP Null Mice.

本文引用的文献

1
Dynamics of fat cell turnover in humans.人类脂肪细胞更新的动态变化
Nature. 2008 Jun 5;453(7196):783-7. doi: 10.1038/nature06902. Epub 2008 May 4.
2
Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.脂肪组织的致病潜力以及脂肪细胞肥大和内脏脂肪增多的代谢后果。
Expert Rev Cardiovasc Ther. 2008 Mar;6(3):343-68. doi: 10.1586/14779072.6.3.343.
3
Subcutaneous adipocyte size and body fat distribution.皮下脂肪细胞大小与身体脂肪分布。
白色脂肪组织的新型增生性扩张是雄性肝脏型脂肪酸结合蛋白缺失小鼠代谢健康肥胖表型的基础。
Cells. 2025 May 22;14(11):760. doi: 10.3390/cells14110760.
4
The microRNA miR-30a blocks adipose tissue fibrosis accumulation in obesity.微小RNA miR-30a可阻止肥胖症中脂肪组织纤维化的积累。
J Clin Invest. 2025 Jun 5;135(15). doi: 10.1172/JCI175566. eCollection 2025 Aug 1.
5
The Advanced Glycation End-Products (AGE)-Receptor for AGE System (RAGE): An Inflammatory Pathway Linking Obesity and Cardiovascular Diseases.晚期糖基化终末产物(AGE)的AGE系统受体(RAGE):连接肥胖与心血管疾病的炎症途径。
Int J Mol Sci. 2025 Apr 14;26(8):3707. doi: 10.3390/ijms26083707.
6
Converted Macrophage Polarization and Expression of COL6α3-Early Predictors of Remodeling Processes in Adipose Tissue of Male Children.转化的巨噬细胞极化与COL6α3的表达——男性儿童脂肪组织重塑过程的早期预测指标
Biomedicines. 2025 Apr 10;13(4):935. doi: 10.3390/biomedicines13040935.
7
HDL-Cholesterol and Triglycerides Dynamics: Essential Players in Metabolic Syndrome.高密度脂蛋白胆固醇与甘油三酯动态变化:代谢综合征中的关键因素
Antioxidants (Basel). 2025 Apr 3;14(4):434. doi: 10.3390/antiox14040434.
8
Adipose cellularity as a measurement of long-term changes in body weight: a Swedish cohort study spanning 1988-2016.脂肪细胞数量作为体重长期变化的一项指标:一项跨越1988年至2016年的瑞典队列研究。
EClinicalMedicine. 2025 Mar 29;82:103165. doi: 10.1016/j.eclinm.2025.103165. eCollection 2025 Apr.
9
Arene Substitutions in Orchid Bibenzyls: Mechanistic Insights into Glucose Uptake and Lipid Metabolism for Targeting Metabolic Disorders.兰花联苄中的芳烃取代:针对代谢紊乱的葡萄糖摄取和脂质代谢的机制洞察
Nutrients. 2025 Mar 21;17(7):1104. doi: 10.3390/nu17071104.
10
Is orbital adipose tissue obesity-privileged? The relationship between small adipocyte size and metabolically healthy state from the view of orbital fat.眼眶脂肪组织是否具有肥胖抗性?从眼眶脂肪的角度看小脂肪细胞大小与代谢健康状态之间的关系。
J Endocrinol Invest. 2025 Mar 22. doi: 10.1007/s40618-025-02568-7.
Am J Clin Nutr. 2008 Jan;87(1):56-63. doi: 10.1093/ajcn/87.1.56.
4
Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis.与胰岛素敏感的肥胖个体相比,胰岛素抵抗的肥胖个体中小脂肪细胞比例增加,这意味着脂肪生成受损。
Diabetologia. 2007 Aug;50(8):1707-15. doi: 10.1007/s00125-007-0708-y. Epub 2007 Jun 5.
5
Fat cell enlargement is an independent marker of insulin resistance and 'hyperleptinaemia'.脂肪细胞增大是胰岛素抵抗和“高瘦素血症”的独立标志物。
Diabetologia. 2007 Mar;50(3):625-33. doi: 10.1007/s00125-006-0572-1. Epub 2007 Jan 10.
6
Relationship between adipocyte size and adipokine expression and secretion.脂肪细胞大小与脂肪因子表达及分泌之间的关系。
J Clin Endocrinol Metab. 2007 Mar;92(3):1023-33. doi: 10.1210/jc.2006-1055. Epub 2006 Dec 12.
7
Adipocyte size and liability to cell death.脂肪细胞大小与细胞死亡易感性
Obes Surg. 2006 Jun;16(6):804-6. doi: 10.1381/096089206777346600.
8
Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression.按大小分离人类脂肪细胞:肥大脂肪细胞呈现出独特的基因表达。
FASEB J. 2006 Jul;20(9):1540-2. doi: 10.1096/fj.05-5678fje. Epub 2006 Jun 5.
9
The role of adipose cell size and adipose tissue insulin sensitivity in the carbohydrate intolerance of human obesity.脂肪细胞大小和脂肪组织胰岛素敏感性在人类肥胖的碳水化合物不耐受中的作用。
J Clin Invest. 1968 Jan;47(1):153-65. doi: 10.1172/JCI105705.
10
Retrospective birth dating of cells in humans.人类细胞的回顾性出生日期测定。
Cell. 2005 Jul 15;122(1):133-43. doi: 10.1016/j.cell.2005.04.028.